Post-Marketing Use of Teduglutide in a Large Cohort of Adults with Short Bowel Syndrome-Associated Chronic Intestinal Failure: Evolution and Outcomes

Teduglutide, a GLP-2 analogue, has been available in France since 2015 to treat short-bowel-syndrome (SBS)-associated chronic intestinal failure (CIF) but it remains very expensive. No real-life data on the number of potential candidates are available. The aim of this real-life study was to assess t...

Descripción completa

Detalles Bibliográficos
Autores principales: de Dreuille, Brune, Nuzzo, Alexandre, Bataille, Julie, Mailhat, Charlotte, Billiauws, Lore, Le Gall, Maude, Joly, Francisca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255523/
https://www.ncbi.nlm.nih.gov/pubmed/37299413
http://dx.doi.org/10.3390/nu15112448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255523/
https://www.ncbi.nlm.nih.gov/pubmed/37299413
http://dx.doi.org/10.3390/nu15112448

Ejemplares similares